Elevated Serum B-Lymphocyte Stimulator Levels in Patients With Familial Lymphoproliferative Disorders - Concepedia

Concepedia

Publication | Open Access

Elevated Serum B-Lymphocyte Stimulator Levels in Patients With Familial Lymphoproliferative Disorders

DOI Full Paper Access

91

Citations

23

References

2006

Year

Anne J. Novak, Deanna M. Grote, Steven C. Ziesmer, Michael Kline, Michelle K. Manske, Susan L. Slager, Thomas E. Witzig, Tait D. Shanafelt, Timothy G. Call, Neil E. Kay,

Journal of Clinical Oncology

Abstract

Our data suggest serum BLyS levels are elevated in patients with familial B-CLL and that elevated BLyS levels correlate with the presence of a T at -871 in the BLyS promoter.

References

	Year	Citations
Clinical staging of chronic lymphocytic leukemia KR Rai, A Sawitsky, Cronkite Ep, Blood	1975	2.7K
Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations Fabienne Mackay, Stephen A. Woodcock, Pornsri Lawton, The Journal of Experimental Medicine	1999	1.5K
BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth Pascal Schneider, Fabienne Mackay, Véronique Steiner, The Journal of Experimental Medicine	1999	1.3K
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease Jane A. Gross, Janet Johnston, Sherri Mudri, Nature Autoimmune DiseaseAutoantibody ProductionHumoral ResponseImmune RegulationImmunology	2000	1.2K
BLyS: Member of the Tumor Necrosis Factor Family and B Lymphocyte Stimulator Paul A. Moore, Ornella Belvedere, A. S. ORR, Science Immunoglobulin SecretionAdaptive Immune SystemImmunologyImmune RegulationPathology	1999	1.1K
Synthesis and release of B-lymphocyte stimulator from myeloid cells Bernardetta Nardelli, Ornella Belvedere, Viktor Roschke, Blood	2001	573
Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice Sanjay D. Khare, Ildiko Sarosi, Xing-Zhong Xia, Proceedings of the National Academy of Sciences B Cell HyperplasiaImmunologyPathologyImmunotherapyInflammation	2000	572
BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone Jérôme Moreaux, Éric Legouffe, Éric Jourdan, Blood	2003	559
Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival Anne J. Novak, Jaime Darce, Bonnie K. Arendt, Blood	2003	552
Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response Eunice N. Hatada, Hayyoung Lee, Michelle R. Tourigny, The Journal of Experimental Medicine InflammationB Cell ProliferationAutoimmune DiseaseHumoral Immune ResponseB Cell Repertoire	2000	424

Page 1